Aprogenex, Inc.

This record represents the public shell of Aprogenex, Inc. Aprogenex, Inc. was engaged in the development, manufacture, and marketing of diagnostic test systems based on its proprietary DNA probe technology to identify the presence or extent of genetic abnormalities and disease, as of March 31, 1997. The company also engaged in the expansion of its technology base through the licensing or acquisition of early-stage pharmaceutical and/or diagnostic product candidates or technologies. The company was founded in 1989 and is based in Houston, Texas. As of April, 1999, Aprogenex, Inc. is in liquidation.